Vuori Kristiina MD 4
4 · Inhibrx Biosciences, Inc. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Vuori Kristiina MD
Director
Transactions
- Purchase
Common Stock
2024-09-11$15.07/sh+6,457$97,307→ 13,776 total - Purchase
Common Stock
2024-09-10$15.00/sh+179$2,685→ 7,319 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.